Freeze-dried Food Market Segment Analysis By Product, Distribution Channel, Region And Forecast Till 2030 : Grand View Research Inc.

San Francisco, 2 March 2023: The Report Post-traumatic Stress Disorder Treatment Market Size, Share & Trends Analysis Report By Drug Class, By Demographics (Adult, Children), By Distribution Channel, By Region, And Segment Forecasts, 2022 – 2030

The global post-traumatic stress disorder treatment market size is expected to reach USD 1.4 billion by 2030, registering a CAGR of 4.7% from 2022 to 2030, according to a new report by Grand View Research, Inc. The increasing disease burden of post-traumatic stress disorder (PTSD), innovation in R&D and emerging drug pipeline, and efforts by government and non-profit organizations to increase awareness are the key factors augmenting the space growth.

The emerging drug pipeline, thereby, expected advancement and drug launches for the treatment of PTSD, is anticipated to offer a lucrative opportunity for market growth over the forecast period. This can be attributed to the presence of Aptinyx’s NYX-783, Bionomics’ BNC210, and Jazz Pharmaceuticals’ JZP150 under phase 2 clinical trials. Ahead of these, Otsuka Pharmaceutical’s Brexpiprazole and Zoloft Combination are in phase 3 trial, creating fierce competition among key players to launch the product in the space.

Events such as the COVID-19 pandemic further support space growth. Several studies have been conducted to understand the impact of the covid 19 pandemic on mental health, increasing the risk of PTSD and rising demand for its treatment. For instance, the August 2021 review article, “COVID?19 and Post traumatic Stress Disorder: The Perfect ‘Storm’ for Mental Health,” clearly demonstrates an increase in the risk of development of PTSD among pandemic affected families and survivors.

Companies are strategically taking initiatives that aid in developing new products, regulatory approvals, and enhancing their product portfolio with geographical expansion. For instance, in March 2022, H. Lundbeck A/S granted the license agreement to Sun Pharmaceutical Industries Ltd., for marketing and distribute of Vortioxetine under the brand name Vortidiftm in the Indian market. 

Access Research Report of Post-traumatic Stress Disorder Treatment Market @ https://www.grandviewresearch.com/industry-analysis/post-traumatic-stress-disorder-treatment-market-report

Post-traumatic Stress Disorder Treatment Market Report Highlights 

• In 2021, antidepressants segment accounted for the largest share and is anticipated to maintain its position over the forecast period owing to FDA approved SSRIs such as Zoloft (sertraline) and Paxil (paroxetine)
• Based on demographics, adult segment is estimated to witness the fastest CAGR of 5.1% during the forecast period owing to presence of rising disorder incidence in adult group, major chunk of patients in this age group and increase in traumatic experiences
• Based on distribution channel, retail pharmacy segment dominated the space in 2021, due to factors such easy of availability, and its compatibility with homecare setting for the long term treatment
• Asia Pacific region is anticipated to experience the fastest growth over the forecast period due to an increased awareness among the population, rise in disposable income, and high disease prevalence of PTSD in developing countries 

List of Key Players of Post-traumatic Stress Disorder (PTSD) Treatment Market

• Lupin Limited
• Pfizer, Inc.
• Aurobindo Pharma Limited
• Merck KGaA
• GlaxoSmithKline plc.
• Otsuka Pharmaceutical Development
• Jazz Pharmaceuticals
• Bionomics
• Aptinyx         
• AstraZeneca 

Access Press Release of Post-traumatic Stress Disorder Treatment Market @ https://www.grandviewresearch.com/press-release/global-post-traumatic-stress-disorder-treatment-market

Post-traumatic Stress Disorder Treatment Market Segmented On The Basis Of Drug Class, Demographics, Distribution Channel, Region And Forecast 2030: Grand View Research Inc.

San Francisco, 2 March 2023: The Report Post-traumatic Stress Disorder Treatment Market Size, Share & Trends Analysis Report By Drug Class, By Demographics (Adult, Children), By Distribution Channel, By Region, And Segment Forecasts, 2022 – 2030

The global post-traumatic stress disorder treatment market size is expected to reach USD 1.4 billion by 2030, registering a CAGR of 4.7% from 2022 to 2030, according to a new report by Grand View Research, Inc. The increasing disease burden of post-traumatic stress disorder (PTSD), innovation in R&D and emerging drug pipeline, and efforts by government and non-profit organizations to increase awareness are the key factors augmenting the space growth.

The emerging drug pipeline, thereby, expected advancement and drug launches for the treatment of PTSD, is anticipated to offer a lucrative opportunity for market growth over the forecast period. This can be attributed to the presence of Aptinyx’s NYX-783, Bionomics’ BNC210, and Jazz Pharmaceuticals’ JZP150 under phase 2 clinical trials. Ahead of these, Otsuka Pharmaceutical’s Brexpiprazole and Zoloft Combination are in phase 3 trial, creating fierce competition among key players to launch the product in the space.

Events such as the COVID-19 pandemic further support space growth. Several studies have been conducted to understand the impact of the covid 19 pandemic on mental health, increasing the risk of PTSD and rising demand for its treatment. For instance, the August 2021 review article, “COVID?19 and Post traumatic Stress Disorder: The Perfect ‘Storm’ for Mental Health,” clearly demonstrates an increase in the risk of development of PTSD among pandemic affected families and survivors.

Companies are strategically taking initiatives that aid in developing new products, regulatory approvals, and enhancing their product portfolio with geographical expansion. For instance, in March 2022, H. Lundbeck A/S granted the license agreement to Sun Pharmaceutical Industries Ltd., for marketing and distribute of Vortioxetine under the brand name Vortidiftm in the Indian market. 

Access Research Report of Post-traumatic Stress Disorder Treatment Market @ https://www.grandviewresearch.com/industry-analysis/post-traumatic-stress-disorder-treatment-market-report

Post-traumatic Stress Disorder Treatment Market Report Highlights 

• In 2021, antidepressants segment accounted for the largest share and is anticipated to maintain its position over the forecast period owing to FDA approved SSRIs such as Zoloft (sertraline) and Paxil (paroxetine)
• Based on demographics, adult segment is estimated to witness the fastest CAGR of 5.1% during the forecast period owing to presence of rising disorder incidence in adult group, major chunk of patients in this age group and increase in traumatic experiences
• Based on distribution channel, retail pharmacy segment dominated the space in 2021, due to factors such easy of availability, and its compatibility with homecare setting for the long term treatment
• Asia Pacific region is anticipated to experience the fastest growth over the forecast period due to an increased awareness among the population, rise in disposable income, and high disease prevalence of PTSD in developing countries 

List of Key Players of Post-traumatic Stress Disorder (PTSD) Treatment Market

• Lupin Limited
• Pfizer, Inc.
• Aurobindo Pharma Limited
• Merck KGaA
• GlaxoSmithKline plc.
• Otsuka Pharmaceutical Development
• Jazz Pharmaceuticals
• Bionomics
• Aptinyx         
• AstraZeneca 

Access Press Release of Post-traumatic Stress Disorder Treatment Market @ https://www.grandviewresearch.com/press-release/global-post-traumatic-stress-disorder-treatment-market

Subscription-based Gaming Market Outlook On The Basis Of Device Type, Gaming Genre, Region And Forecast To 2030 : Grand View Research Inc.

San Francisco, 1 March 2023: The Report Subscription-based Gaming Market Size, Share & Trends Analysis Report By Device Type (Smartphone, P.C., Console), By Gaming Genre (Action, Adventure), By Region, And Segment Forecasts, 2022 – 2030

The global subscription-based gaming market size is anticipated to reach USD 24.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.8% from 2022 to 2030. The increasing adoption of various technological advancements such as AI-based rendering, the usage of big data, and the metaverse is expected to create growth opportunities for subscription-based gaming service providers in the global market. In April 2021, Facebook launched the Oculus Quest 2 standalone wireless virtual reality headset for USD 300, which had 50% more pixels than the previous model. Moreover, the market is witnessing a rise in popularity owing to factors such as the growth of the mobile gaming industry and the increase in penetration of high-speed internet. For instance, in 2022, according to a Gaming Spotlight 2022 report, mobile gaming accounted for USD 136 billion out of a total of USD 222 billion gaming market.

The COVID-19 pandemic had a positive impact on the market. A global increase in COVID-19 cases slowed the economy, and many corporations were shutting down as a result of partial or total lockdown. However, despite the pandemic, video gaming firms continued to provide their services. The pandemic resulted in an increase in data usage globally, for instance, according to Verizon Networks data consumption for gaming purposes saw an increase during the pandemic. There was a 75% increase in data consumption from March 8 to 15 in 2020, which indicated that many people used gaming as a means to spend their time. The use of virtual private networks (VPNs) climbed by 34%, while online traffic increased by 20% and video bandwidth consumption by 12%.

Access Research Report of Subscription-based Gaming Market @ https://www.grandviewresearch.com/industry-analysis/subscription-based-gaming-market-report

Subscription-based Gaming Market Report Highlights

• In the device type segment, P.C. dominated the market with a share of over 55.0% in 2021. This is attributed to the increasing demand for cloud gamingand game content. For instance, according to the data published in 2021 by Ampere Analysis, an entertainment industry-specific research firm, the market for PC subscriptions for cloud gaming and game content in North America and Europe was valued at USD 3.7 billion, which grew by 57% compared to 2020. The smartphone segment is expected to register the highest CAGR of 16.8% over the forecast period owing to increasing consumer spending. For instance, according to a study published by IDC and data.ai in March 2022, consumers spent more than USD 1.6 billion every week on mobile games on the Google Play store as well as the iOS App Store in the first quarter of 2022.
• The action segment dominated the market with a share of over 20.0% in 2021. According to ESAC in 2022, the most popular categories were adventure and action preferred by 24% of adults and 33% of children and teenagers. The adventure genre is expected to register the highest CAGR of 13.5% over the forecast period owing to the launch of a wide range of new games in the adventure genre such as God of War Ragnarok and Star Ocean in 2022, 2023, and beyond
• Asia Pacific held the largest share of over 40.0% in 2021 and is expected to exhibit the highest CAGR over the forecast period. The growth of the regional market can be attributed to growth in the subscription of mobile and internet. In 2022, according to the GSMA report, in the developed Asia Pacific region, which includes Australia, Japan, Singapore, and South Korea, the percentage of 5G subscribers will grow by an average of 67%

List of Key Players of Subscription-based Gaming Market

• Amazon Inc.
• Apple Inc.
• Electronic Arts Inc.
• Humble Bundle
• Blacknut
• NVIDIA Corporation
• Microsoft Corporation
• Google LLC
• Ubisoft Entertainment
• Sony Interactive Entertainment Inc.

Access Press Release of Subscription-based Gaming Market @ https://www.grandviewresearch.com/press-release/global-subscription-based-gaming-market

Variable Rate Technology Market Segmented On The Basis Of Component, Technology, Crop Type, Farm Size, Application, Region And Forecast 2030: Grand View Research Inc.

San Francisco, 1 March 2023: The Report Variable Rate Technology Market Size, Share & Trends Analysis Report By Component (Hardware, Software, Services), By Technology (Map-based, Sensor-based), By Crop Type, By Farm Size, By Application, By Region, And Segment Forecasts, 2022 – 2030

The global variable rate technology market size is anticipated to reach USD 10.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to witness a CAGR of 12.3% over the forecast period. Variable Rate Technology (VRT) is a tool that allows farmers to apply water, fertilizer, seed, and chemicals at different and suitable rates across a field. When a producer uses VRT to apply the correct amount of nutrients blended with the ideal seeding rate, they can produce more agricultural produce from every acre of the land and also reduce the wastage of input materials. Produce can be maximized by customizing each field zone’s seeding and crop nutrition applications.

The fertility profile of different field areas is checked and applied with complementary seed, fertilizer, and irrigation applications; these pairings are known as prescriptions. The variable rate technology market has a vast scope for expansion. To realize this potential farm operation services, integration services, and other services are included. Numerous global businesses offer these services, including farm mapping, soil and moisture management, boundary mapping, and others. Companies such as Trimble, Inc. offer variable rates hardware technologies such as planting solutions, application control products, and displays, guidance systems, among others.

Due to its various inclusive features of variable rate technology, including crop health monitoring, data security, data administration, and stock management, the variable rate technology software market are predicted to expand significantly in the coming years. The variable-rate hardware solutions, including GPS/DGPS receivers, portable computers, sensors, and yield monitor systems, made up about half of the market for VRT offerings in 2021. The COVID-19 pandemic outbreak temporarily decreased demand for expensive agricultural machinery and related technology. The agriculture variable rate technology business picked up quickly post-pandemic. Due to the severe labor scarcity during the pandemic, which adversely affected the agriculture sector, the farmers were compelled to deploy agriculture-related technologies rather than depending on the workforce.

It remains challenge the industry is expected to face is data privacy and security. The key players in the market are focusing on new product development to increase their market share. For instance, the XAG P40 Agricultural Drone, a new generation of agricultural drones specifically created for smallholder farms, was introduced in February 2021 by the agricultural machinery manufacturer XAG, based in China.

The XAG P40 Agricultural Drone can carry up to 40 kilograms and cover up to 20 hectares in an hour. It is designed for big field areas. This aids in defending a huge expanse of land from pests, diseases, and weeds. The medium-to-large farm owners have hugely benefitted from the product. In December 2021, NX9, a software suite that delivers ISOBUS applications and core technologies for agricultural equipment and corresponding intellectual property rights, was acquired by CNH Industrial N.V. This acquisition builds upon the company’s strategic momentum to efficiently develop and innovate products in the precision agriculture space and provide superior value for its farming clients.

Access Research Report of Variable Rate Technology Market @ https://www.grandviewresearch.com/industry-analysis/variable-rate-technology-market-report

Variable Rate Technology Market Report Highlights

• Variable Rate Technology is gaining traction owing to the fast adoption of cutting-edge technology to lower labor costs in agriculture across the globe
• The hardware segment dominated the market in 2021 with a market share of about 69.87%. Guidance and Steering systems are the largest sub-segment of a hardware component in revenue
• The service segment is anticipated to witness a CAGR of 14.3% during the forecast period. The farm operation services sub-segment generated the highest revenue in 2021 in the service segment, accounting for USD 258.1 million. There is a growing demand for climate information, analytics, and data services
• The map-based technology segment contributed to more than half of the market revenue of technology component in 2021 as satellites are mainly used for farm mapping because they provide accurate results within a limited time, and the segment is anticipated to grow at a CAGR of 11.3% over the forecast period
• Cereals & Grains are the most grown crops, and therefore contributed to the highest revenue share in the year 2021, and is anticipated to register a CAGR of 12.8% over a forecast period.
• In August 2021, Bear Flag Robotics was acquired by Deere & Company. The agreement complements John Deere’s goal to produce more intelligent machines with cutting-edge technology to fulfill unique client requirements, accelerate the farming sector, development and delivery of automation and autonomy 

List of Key Players of Variable Rate Technology Market

• Deere & Company
• Trimble, Inc.
• Agco Corporation
• Topcon Corporation
• CNH Industrial N.V.
• Kubota Corporation
• AG Leader Technology
• Teejet Technologies
• Valmont Industries, Inc.
• Lindsay Corporation

Access Press Release of Variable Rate Technology Market @ https://www.grandviewresearch.com/press-release/global-variable-rate-technology-market

Tangential Flow Filtration Market Focusing On The Basis Of Product, Technology, Application, End-User, Region And Forecast 2030: Grand View Research Inc.

San Francisco, 1 March 2023: The Report Tangential Flow Filtration Market Size, Share & Trends Analysis Report By Product (Single-use, Membrane Filters), By Technology (Ultrafiltration, Microfiltration), By Application, By End-user, By Region, And Segment Forecasts, 2022 – 2030

The global tangential flow filtration market size is estimated to reach USD 4.98 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 11.53% from 2022 to 2030. The major factors contributing to the market growth are the advantages offered by tangential flow filtration (TFF) over normal flow filtration, the increasing demand for vaccines and therapeutics derived from bioprocessing operations, and the rising investments for exhaustive R&D activities to develop new technologies in TFF.

The use of TFF technology increased during the COVID-19 pandemic as the separation process was widely employed during the vaccine manufacturing process. TFF products observed an increased adoption during COVID-19 research for the development and manufacturing of vaccines as treatment plans. The pandemic also witnessed an increase in the usage of single-use bioprocessing systems, which further fueled the market expansion. In addition, several initiatives by the governments and key manufacturers were introduced to boost the vaccine development for curbing the spread of SARS-CoV-2 infection. For instance, in April 2021, Meissner Filtration Products, Inc. announced that it has secured a contract of USD 13.4 million from the U.S. government, BARDA (Biomedical Advanced Research and Development Authority) to expand its capacity and produce single-use systems to support the manufacturing of vaccines for COVID-19. Thereby, the increased production of vaccines has positively impacted the TFF product demand and fueled its growth.

TFF or sometimes referred to as cross-flow filtration is a technique used for the separation and purification of molecules, wherein the feed solution flows in a parallel direction to the membrane filter. During this process, some of the flow streams pass through the filter while the rest is concentrated by recirculation in the system. The TFF technology is utilized across both upstream and downstream processes due to its numerous advantages such as low running costs, enhanced control and efficiency, reduced cross-contamination, easy scale-up or down, and increased shelf life. These advantages have allowed TFF application in a range of fields such as biochemistry, molecular biology, and immunology. Additionally, the increasing demand for biopharmaceuticals due to lesser side effects, personalized treatments, and novel therapies has resulted in the expansion of manufacturing capabilities. CMOs and CROs also witnessed a rise in the manufacturing of vaccines and therapeutics due to the upswing in the demand for commercial biopharmaceuticals. For instance, in June 2022, Merck KGaA announced expanding its existing CDMO facility in Wisconsin, USA. This new expansion project of USD 58 million (EUR 59 million) is targeted to increase the production of highly potent active pharmaceutical ingredients for meeting the growing demand for therapies for critical cancer. The rise in the manufacturing of and demand for biopharmaceuticals attributes to the adoption of TFF products across harvesting, separation, and purification processes, therefore propelling the growth of the marketplace.

Access Research Report of Tangential Flow Filtration Market @ https://www.grandviewresearch.com/industry-analysis/tangential-flow-filtration-market-report

Tangential Flow Filtration Market Report Highlights

• By product, membrane filters held the largest share in 2021. The presence of various products with different pore sizes and different types of filters that can be employed for multiple purposes propels the segment growth
• By technology, in 2021, the microfiltration segment held the largest share. The segment growth is owing to the high usage of microfiltration membranes in manufacturing processes during cell separation and product recovery stages
• By application, protein purification dominated the market in 2021. Increased demand for recombinant protein-based therapeutics and the advantages of TFF technology boost the usage of these filtration products during the manufacturing processes, thus leading to segment growth
• By end-user, pharmaceutical and biotechnology companies held the largest share in 2021. New drug discovery programs, rising investments, and an extended R&D pipeline for new therapy development are contributing to the revenue generation
• North America held the largest share in 2021. The key factors fueling the revenue growth are the prevalence of disorders and diseases, developed healthcare infrastructure, presence of major market players, and supportive initiatives by the government

List of Key Players in Tangential Flow Filtration Market

• Danaher Corporation
• Sartorius AG
• Parker-Hannifin Corporation
• Alfa Laval AG
• Merck KGaA
• Repligen Corporation
• ABEC, Inc.
• Sterlitech Corporation
• Synder Filtration, Inc.
• Meissner Filtration Products, Inc.

Access Press Release of Tangential Flow Filtration Market @ https://www.grandviewresearch.com/press-release/global-tangential-flow-filtration-market

Vulvovaginal Candidiasis Treatment Market In-Depth Research On Basis By Drug Class, Route Of Administration, Distribution Channel, Region And Forecast To 2030 : Grand View Research Inc.

San Francisco, 1 March 2023: The Report Vulvovaginal Candidiasis Treatment Market Size, Share & Trends Analysis Report By Drug Type (Clotrimazole, Fluconazole, Terconazole), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2022 – 2030

The global vulvovaginal candidiasis treatment market size is expected to reach USD 1.64 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.39% from 2022 to 2030. The increasing disease burden of VVC, approval of novel drugs with the ability to address the unmet needs, and efforts by government & non-profit organizations to increase awareness are among the key factors augmenting the industry growth. According to the NCBI article, globally, around 75% of women suffer from this disease once in their life.Vulvovaginal candidiasis is the second most common infection in women, affecting around 138 million women globally.

About 10-20% of women report complicated disease conditions, which are increasing annually. Moreover, the NCBI article reports an upsurge in recurrent infection incidences. Thus, the rising prevalence of the disease is boosting the treatment demand, thereby driving industry growth.Azoles, such as fluconazole, are indicated as the first line of treatment and held a significant share of the market, however, in recent years, there has been a surge in azole resistance cases, which led to rising in recurring disease cases. However, novel drugs, such as VIVJOA and BREXAFEMME, are effectiveagainst recurring VVC. In addition, the presence of over-the-counter intravaginal agents, which enables easy patient treatment access, supports the market growth.

This includes products, such as miconazole cream, clotrimazole cream, and tioconazole ointment. They are indicated to treat mild to moderate conditions and are used as maintenance therapy. The industry is saturated with generic products, which could slow down growth. However, key players, such as Mycovia Pharmaceuticals and SCYNEXIS, Inc., are engaged in strategic initiatives like new product development and launches, which are anticipated to propel the market growth over the forecast period. For instance, in July 2022, Mycovia Pharmaceuticals launched VIVJOA for recurrent VVC. The company has already received VIVJOA approval in Asian, European, and Latin American countries. In September 2021, SCYNEXIS, Inc. launched BREXAFEMME in the U.S., the first oral non-azole therapeutic indicated for VVC.

Access Research Report of Vulvovaginal Candidiasis Treatment Market @ https://www.grandviewresearch.com/industry-analysis/vulvovaginal-candidiasis-treatment-market-report

Vulvovaginal Candidiasis Treatment Market Report Highlights

• In 2021, the fluconazole segment accounted for the largest share owing to its high prescription rate and the non-availability of other drugs with similar efficacy
• The topical segment is estimated to grow at a steady CAGR during the forecast period due to the presence of OTC and prescription formulations, such as azole creams and ointments
• Based on distribution channel, the retail pharmacy segment dominated the industry in 2021 due to the ease of availability and the presence of OTCs drugs
• Asia Pacific is anticipated to experience the fastest CAGR over the forecast period due to increased awareness among the population, rise in disposable income, and high prevalence of VVC in developing countries

List of Key Players of Vulvovaginal Candidiasis Treatment Market

• Astellas Pharma Inc.
• Mycovia Pharmaceuticals, Inc.
• Basilea Pharmaceutica Ltd.
• Scynexis, Inc.
• Grupo Ferrer Internacional S.A.
• Pfizer, Inc.
• Cadila Pharmaceuticals
• Bayer AG.
• Bristol-Myers Squibb Company

Access Press Release of Vulvovaginal Candidiasis Treatment Market @ https://www.grandviewresearch.com/press-release/global-vulvovaginal-candidiasis-treatment-market